This is a synthetic peptide designed for use in combination with anti-PLD3 antibody (Catalog #: ARP44768_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
PLD3
(Phospholipase D family member 3 (PLD3))
Synonyme
DDBDRAFT_0204850 Peptide, DDBDRAFT_0231505 Peptide, DDB_0204850 Peptide, DDB_0231505 Peptide, DDBDRAFT_0187542 Peptide, DDBDRAFT_0220113 Peptide, DDB_0187542 Peptide, DDB_0220113 Peptide, HU-K4 Peptide, HUK4 Peptide, Sam-9 Peptide, phospholipase D3 Peptide, phospholipase D family member 3 Peptide, phospholipase D family, member 3 Peptide, CpipJ_CPIJ017227 Peptide, pldZ Peptide, pldY Peptide, DICPUDRAFT_30308 Peptide, PLD3 Peptide, Pld3 Peptide
Hintergrund
PLD3 is a ingle-pass type II membrane protein. It belongs to the phospholipase D family. PLD3 contains 2 PLD phosphodiesterase domains. The exact function of PLD3 remains unknown.